Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)

NCT04550351 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronavirus

Interventions

BIOLOGICAL: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cell) low-dose group
BIOLOGICAL: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cells) high-dose group
BIOLOGICAL: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cells) placebo group

Sponsor

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.